• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性阿尔茨海默病中胆固醇代谢相关基因的改变。

Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.

机构信息

Centre for Studies on the Prevention of Alzheimer's Disease, Douglas Mental Health University Institute, Montreal, Quebec, Canada; Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Centre for Studies on the Prevention of Alzheimer's Disease, Douglas Mental Health University Institute, Montreal, Quebec, Canada.

出版信息

Neurobiol Aging. 2018 Jun;66:180.e1-180.e9. doi: 10.1016/j.neurobiolaging.2018.01.018. Epub 2018 Feb 9.

DOI:10.1016/j.neurobiolaging.2018.01.018
PMID:29503034
Abstract

Genome-wide association studies have identified several cholesterol metabolism-related genes as top risk factors for late-onset Alzheimer's disease (LOAD). We hypothesized that specific genetic variants could act as disease-modifying factors by altering the expression of those genes. Targeted association studies were conducted with available genomic, transcriptomic, proteomic, and histopathological data from 3 independent cohorts: the Alzheimer's Disease Neuroimaging Initiative (ADNI), the Quebec Founder Population (QFP), and the United Kingdom Brain Expression Consortium (UKBEC). First, a total of 273 polymorphisms located in 17 cholesterol metabolism-related loci were screened for associations with cerebrospinal fluid LOAD biomarkers beta amyloid, phosphorylated tau, and tau (from the ADNI) and with amyloid plaque and tangle densities (from the QFP). Top polymorphisms were then contrasted with gene expression levels measured in 134 autopsied healthy brains (from the UKBEC). In the end, only SREBF2 polymorphism rs2269657 showed significant dual associations with LOAD pathological biomarkers and gene expression levels. Furthermore, SREBF2 expression levels measured in LOAD frontal cortices inversely correlated with age at death; suggesting a possible influence on survival rate.

摘要

全基因组关联研究已经确定了几个胆固醇代谢相关基因是晚发性阿尔茨海默病(LOAD)的顶级风险因素。我们假设特定的遗传变异可以通过改变这些基因的表达来充当疾病修饰因子。使用来自 3 个独立队列的现有基因组、转录组、蛋白质组和组织病理学数据进行了靶向关联研究:阿尔茨海默病神经影像学倡议(ADNI)、魁北克创始人群体(QFP)和英国大脑表达联盟(UKBEC)。首先,筛选了位于 17 个胆固醇代谢相关基因座中的 273 个多态性,以与脑脊液 LOAD 生物标志物β淀粉样蛋白、磷酸化 tau 和 tau(来自 ADNI)以及淀粉样斑块和缠结密度(来自 QFP)相关联。然后,将顶级多态性与在 134 例尸检健康大脑中测量的基因表达水平进行对比(来自 UKBEC)。最后,只有 SREBF2 多态性 rs2269657 显示出与 LOAD 病理生物标志物和基因表达水平的双重显著关联。此外,在 LOAD 额叶皮质中测量的 SREBF2 表达水平与死亡年龄呈负相关;表明可能对存活率有影响。

相似文献

1
Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.散发性阿尔茨海默病中胆固醇代谢相关基因的改变。
Neurobiol Aging. 2018 Jun;66:180.e1-180.e9. doi: 10.1016/j.neurobiolaging.2018.01.018. Epub 2018 Feb 9.
2
ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.ABCA7基因通过调节β淀粉样蛋白病理来赋予阿尔茨海默病风险。
J Alzheimers Dis. 2016 Mar 21;52(2):693-703. doi: 10.3233/JAD-151005.
3
Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.APOE基因分型对阿尔茨海默病谱系中临床和神经影像学生物标志物的多重影响。
Mol Neurobiol. 2016 Sep;53(7):4539-47. doi: 10.1007/s12035-015-9388-7. Epub 2015 Aug 23.
4
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.阿尔茨海默病中脑脊液淀粉样蛋白-β与氟代硼吡咯(florbetapir)成像的独立信息
Brain. 2015 Mar;138(Pt 3):772-83. doi: 10.1093/brain/awu367. Epub 2014 Dec 24.
5
Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.rs3846662变异对HMGCR mRNA和蛋白水平以及阿尔茨海默病病理标志物的影响。
J Mol Neurosci. 2016 Jan;58(1):109-19. doi: 10.1007/s12031-015-0666-7. Epub 2015 Nov 5.
6
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.患者脑脊液中的 tau 和淀粉样蛋白-β1-42。
Brain. 2015 Sep;138(Pt 9):2716-31. doi: 10.1093/brain/awv181. Epub 2015 Jun 30.
7
Marking the markers of Alzheimer's: too good to diagnose, too bad to use?标记阿尔茨海默病的标志物:诊断效果太好而无法使用,使用效果太差而无法诊断?
Neuropsychopharmacol Hung. 2012 Sep;14(3):165-76.
8
Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease.SORL1基因中的遗传变异对阿尔茨海默病表现的影响。
Neurobiol Aging. 2015 Mar;36(3):1605.e13-20. doi: 10.1016/j.neurobiolaging.2014.12.007. Epub 2014 Dec 11.
9
Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.阿尔茨海默病相关风险基因座对脑脊液生物标志物及疾病进展的影响:一种多基因风险评分方法
J Alzheimers Dis. 2015;43(2):565-73. doi: 10.3233/JAD-140777.
10
Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.糖原合成酶激酶3β(GSK3B)的基因变异与阿尔茨海默病的生物标志物及认知功能相关。
J Alzheimers Dis. 2015;44(4):1313-22. doi: 10.3233/JAD-142025.

引用本文的文献

1
Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer's Disease? A Review of Recent Pertinent Observations from Molecular Biology.海马体灌注不足和ATP耗竭是阿尔茨海默病发病的主要因素吗?来自分子生物学的近期相关观察综述
Int J Mol Sci. 2025 Jul 29;26(15):7328. doi: 10.3390/ijms26157328.
2
Lipid droplet accumulation in microglia and their potential roles.小胶质细胞中的脂滴积累及其潜在作用。
Lipids Health Dis. 2025 Jun 14;24(1):215. doi: 10.1186/s12944-025-02633-3.
3
Regulation of lipid dysmetabolism and neuroinflammation linked with Alzheimer's disease through modulation of Dgat2.
通过调节二酰甘油酰基转移酶2(Dgat2)来调控与阿尔茨海默病相关的脂质代谢异常和神经炎症。
bioRxiv. 2025 Mar 11:2025.02.18.638929. doi: 10.1101/2025.02.18.638929.
4
Dynamic functional network connectivity and its association with lipid metabolism in Alzheimer's disease.阿尔茨海默病中动态功能网络连接及其与脂代谢的关系。
CNS Neurosci Ther. 2024 Sep;30(9):e70029. doi: 10.1111/cns.70029.
5
Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK.tau 病脑中的小胶质细胞脂滴积累受神经元 AMPK 调节。
Cell Metab. 2024 Jun 4;36(6):1351-1370.e8. doi: 10.1016/j.cmet.2024.03.014. Epub 2024 Apr 23.
6
Gut microbiota-host lipid crosstalk in Alzheimer's disease: implications for disease progression and therapeutics.肠道微生物群-宿主脂质串扰在阿尔茨海默病中的作用:对疾病进展和治疗的影响。
Mol Neurodegener. 2024 Apr 16;19(1):35. doi: 10.1186/s13024-024-00720-0.
7
Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders.核受体 PPARα 作为与脂质代谢紊乱相关疾病的治疗靶点。
Nutrients. 2023 Nov 13;15(22):4772. doi: 10.3390/nu15224772.
8
The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.构建阿尔茨海默病及相关痴呆的多领域风险模型。
J Alzheimers Dis. 2023;96(2):535-550. doi: 10.3233/JAD-221292.
9
Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation.抑制 ACAT 作为阿尔茨海默病的治疗靶点与载脂蛋白 E4 脂质化无关。
Neurotherapeutics. 2023 Jul;20(4):1120-1137. doi: 10.1007/s13311-023-01375-3. Epub 2023 May 8.
10
Statins and cognition: Modifying factors and possible underlying mechanisms.他汀类药物与认知:修饰因素及潜在机制
Front Aging Neurosci. 2022 Aug 15;14:968039. doi: 10.3389/fnagi.2022.968039. eCollection 2022.